Gene Query: POP1

Dataset Description Geneva Score
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 53.64
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 33.6
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 30.61
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 24.79
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 23.9
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 23.57
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 22.28
IDH3a KO RNA-seq 21.44
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 20.31
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 19.57
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 18.5
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 18.46
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 17.79
MYCi361 regulates MYC target genes 17.73
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 17.48
Epigenetic reprogramming of melanoma cells by vitamin C treatment 16.94
Peptidomimetic blockade of MYB in acute myeloid leukemia 16.92
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 16.92
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 16.91
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 16.83
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 16.83
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 16.5
Genome-wide chromatin analysis of Ewing sarcoma 16.5
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 16.49
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 16.49
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 16.35
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 15.93
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 15.64
A transcriptome-wide divergence in protein translation scales with LIN28B expression 14.82
LncRNA-GAS5 negative regulation of YAP-target genes expression 14.16
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 14.0
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 14.0
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 13.9
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 13.74
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 13.74
Knockdown of ADNP in HCT116 colon cancer cells 13.74
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 13.38
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 13.33
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 13.33
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 13.08
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 13.08
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 12.89
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 12.89
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 12.49
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 12.31
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 12.22
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 12.14
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 12.0
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 11.71
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 11.55
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 11.43
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 11.23
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 11.16
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 11.11
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 11.11
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 11.08
Control of prostate tumour growth by the long non-coding RNA GHSROS 11.05
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 10.93
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 10.79
TGF-β regulation of miRNA expression in pancreatic cancer 10.43
Cajal bodies are linked to genome conformation 10.41
Cajal bodies are linked to genome conformation [RNA-Seq] 10.41
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 10.36
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 10.32
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 10.32
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 10.2
LNCaP treated with iBET 10.08
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 10.04
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 9.97
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 9.91
RNAseq Analysis in glioblastoma cells treated with Mepazine 9.87
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 9.78
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 9.67
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 9.62
Hypoxic transcriptome of SQ20B human head and neck cancer cells 9.54
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 9.46
U1 snRNP telescripting regulates size-function stratified human genome 9.46
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 9.37
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 9.32
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 9.3
Gene expression changes upon drug withdrawal (Mel888 cell line) 9.28
Seletive inhibition of CDK9 in DLBCL cell lines 9.25
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 9.25
Identification of Sin3B regulated genes during quiescence 9.23
The landscape of alternative splicing in aggressive prostate cancers 9.21
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 9.08
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 9.08
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 9.05
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 9.04
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  8.99
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 8.81
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 8.81
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 8.8
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 8.8
Chromatin landscape of human visceral and subcutaneous adipocytes 8.74
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 8.65
RNA sequencing analysis of selumetinib-resistant CRC cells lines 8.59
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 8.51
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 8.43
Genome-wide analysis of the Integrator complex (HTS) 8.42
Genome-wide analysis of the Integrator complex 8.42
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 8.37
Transcriptomic analysis of ERR alpha orphan nuclear receptor 8.3
Effect of FGF13 depletion on the H460 cell line 8.16
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 8.15
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 8.13
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 8.12
Developmental stage specific chromosome architecture in human erythroid cells 8.05
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 8.05
Genes significantly down or Up-regulated upon RNF219 knockdown 8.04
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 8.03
Endothelial gene expression analysis 7.95
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 7.95
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 7.89
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 7.85
RNA-seq of human aneuploid cell lines with Trisomy 21 7.84
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 7.74
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 7.66
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 7.63
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 7.63
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 7.62
6mer seed toxicity in tumour suppressive microRNAs 7.61
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 7.54
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 7.41
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 7.25
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 7.23
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 7.21
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 7.09
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 7.09
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 7.08
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 7.05
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 7.05
Androgen Receptor-regulated genes in prostate cancer cells 7.02
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 7.02
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 7.0
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 7.0
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 6.9
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 6.88
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 6.85
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 6.82
Inhibition of TNBC metastasis by Gpx1 6.78
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 6.76
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 6.74
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 6.7
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 6.69
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 6.66
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 6.61
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 6.59
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 6.55
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 6.54
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 6.54
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 6.53
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 6.5
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 6.5
Overexpression of NFIB and YBX1 in MCF-7 cells 6.48
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 6.45
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 6.38
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 6.22
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 6.22
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 6.19
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 6.18
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 6.18
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.17
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 6.17
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 6.15
Genome wide miR-191 target profile determined by RIP and gene expression profiling 6.15
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 6.07
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 6.07
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 6.06
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 6.06
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 6.05
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 6.04
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 6.01
Genome wide expression change by RNF168 knocking down in NEC cells 5.98
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 5.97
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 5.96
BASP1 modifies the Tamoxifen response 5.93
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 5.85
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 5.82
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 5.82
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 5.79
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 5.74
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 5.73
A Unique Epigenomic Landscape Defines Human Erythropoiesis 5.73
RNAseq Study in CC-671 Treated Cal-51 Cells 5.72
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 5.7
Gene Expression Profiling of SPOP Knocked Down Cell 5.69
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 5.68
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 5.65
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 5.64
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 5.64
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 5.64
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 5.64
Gene expression changes caused by KRAS in MCF-10A 5.63
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 5.62
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 5.62
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 5.62
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 5.61
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 5.59
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 5.52
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 5.51
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 5.47
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 5.43
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.42
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 5.4
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 5.39
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 5.35
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 5.31
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 5.28
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 5.27
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 5.25
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 5.24
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 5.23
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 5.23
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 5.16
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 5.14
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.13
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 5.12
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 5.09
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 5.08
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 5.07
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 5.05
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 5.05
FOXD3 is a novel tumor suppressor in lung cancer 5.04
ADAR1-editing of cellular and measles virus-derived duplex RNA 5.03
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 5.03
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 5.03
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 5.03
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 5.03
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 5.0
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 5.0
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 5.0
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 4.99
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.98
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 4.93
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 4.92
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 4.9
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 4.89
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 4.89
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 4.89
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 4.89
SNHG5 siRNA knock down in HCT116 cells 4.88
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 4.87
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 4.86
RNA sequencing of BT142 and TS603 cell lines 4.83
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 4.83
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 4.83
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.79
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 4.79
Global gene expression profile of dasatinib-resistant RCH-ACV cells 4.76
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 4.71
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 4.69
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 4.69
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 4.68
METTL3 promotes translation in human cancer cells 4.68
Tracking of dCas9-methyltransferase footprints 4.68
RNA sequencing of GlyH-101-treated MCF-7 cell line 4.65
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 4.64
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 4.61
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 4.55
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.54
SRSF1 role in cellular gene expression and splicing 4.52
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 4.52
ETV7 and interferon response 4.52
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 4.49
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 4.48
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 4.45
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 4.45
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 4.44
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 4.44
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 4.42
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 4.4
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 4.4
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 4.39
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.36
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 4.33
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 4.33
The DPYSL2 gene connects mTOR and schizophrenia 4.33
CD95/Fas ligand mRNA is toxic to cells 4.32
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 4.26
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.23
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 4.22
Polarized B -cell functions 4.21
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 4.2
JunB control of keratinocyte-mediated inflammation [RNA-seq] 4.2
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.19
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.16
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 4.16
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 4.13
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 4.12
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 4.12
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 4.11
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 4.1
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 4.1
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 4.1
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.1
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 4.09
Real-time observation of light-controlled transcription in living cells 4.06
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 4.03
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 4.03
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 4.03
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 4.02
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.02
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 4.0
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 3.99
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 3.95
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 3.93
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 3.93
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.93
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.92
Characterization of parental and rociletinib-resistant derived H1975 cell lines 3.91
The effect of PPARG inhibition on human angiomyolipoma cells 3.88
RNA-seq of RKO cells with cTAZ KO or putback 3.87
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.87
PRDM1 inhibits proliferation of human colon cancer organoids 3.86
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 3.84
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 3.84
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 3.84
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 3.84
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 3.83
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 3.82
MYCi975 regulates MYC target genes 3.82
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 3.75
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 3.74
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 3.73
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 3.72
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 3.72
SLIGRL-induced gene expression changes in NHEK cells 3.71
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 3.69
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 3.68
Silencing SPIB in attached and floating state of H1703 lung cancer cells 3.68
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 3.67
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 3.64
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 3.63
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 3.61
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.59
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 3.55
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 3.52
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 3.48
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.47
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 3.42
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 3.38
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 3.37
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 3.36
RNA-seq in transgenic cells 3.36
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 3.34
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.32
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 3.31
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 3.26
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 3.24
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 3.22
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 3.22
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 3.21
Illumina Total RNA-seq in HeLa 3.15
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 3.09
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 3.07
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.05
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.05
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.05
Effect of drugs on transcriptomic profiles 3.02
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 3.0
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 2.99
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 2.99
Transcriptomic analysis of LSD1 2.95
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 2.94
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 2.92
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 2.92
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.83
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 2.71
Positively selected enhancer elements endow tumor cells with metastatic competence 2.7
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 2.68
Searching for target genes of miR-508/509/506/514 in HCT116 cells 2.65
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 2.57
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 2.57
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.56
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.53
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.45
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.45
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.4
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.4
U2AF1 mutations alter splice site recognition in hematological malignancies 2.38
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.37
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 2.33
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.32
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.29
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 2.25
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 2.2
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 2.2
Transcriptional changes in lymphoma cells induced by LSD1 depletion 2.2
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.16
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.14
HEK293 TFAM Knockout Expression Study 2.14
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.13
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.13
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.1
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 2.07
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 2.07
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.03
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.03
SF3B1 Degron knockdown RNA-seq 2.03
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 2.0
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 2.0
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 1.96
Selective expression of long non-coding RNAs in a breast cancer cell progression model 1.94
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 1.93
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 1.93
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 1.92
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.91
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.91
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.91
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.88
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 1.86
KSDM1b Role in Ewing Sarcoma 1.82
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.65
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.64
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.59
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.58
CDK4/6 inhibitor resistance in prostate cancer 1.57
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 1.54
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.54
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 1.53
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.52
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.52
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 1.51
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.5
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 1.49
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 1.49
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 1.47
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 1.47
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 1.43
RNA-seq analysis upon ARID1B overexpression 1.42
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.42
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 1.4
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 1.4
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.36
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 1.32
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.29
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.28
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 1.28
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 1.28
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 1.26
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.2
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.18
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.15
CD86 regulates a pro-survival signal in myeloma cells 1.12
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.06
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.0
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.98
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 0.98
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.97
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 0.92
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 0.92
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.87
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.83
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.82
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.82
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 0.81
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 0.81
RNA-seq of cancer cell lines treated with T-025 0.79
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.71
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.68
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 0.66
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.65
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.64
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.63
RNA editing in nascent RNA affects pre-mRNA splicing 0.62
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.61
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.6
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.58
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.57
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.57
Targeting MTHFD2 in Acute Myeloid Leukemia 0.52
Downregulation of LATS kinases alters p53 to promote cell migration 0.51
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 0.5
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.49
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.45
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 0.44
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.42
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.38
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.37
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.35
Gene expression changes due to PARP knockdown in human cells 0.29
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.25
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.21
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.18
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.17
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.15
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.15
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.15
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.15
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.09
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.09
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.08
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.08
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.07
Gene expression analysis of breast cancer cell-lines 0.07
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.07
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 0.07
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.06
6mer seed toxicity in viral microRNAs 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation